Nedlands, Australia

Wayne Robert Thomas

USPTO Granted Patents = 27 


Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 205(Granted Patents)


Location History:

  • Nedlands, Western Australia, 6009, AU (1999)
  • Perth, AU (2007)
  • Nedlands, AU (1995 - 2016)

Company Filing History:


Years Active: 1995-2016

Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Wayne Robert Thomas: A Pioneer in Allergen Research

Introduction

Wayne Robert Thomas, based in Nedlands, Australia, is a renowned inventor with an impressive portfolio of 27 patents. His innovative work primarily focuses on the development of isolated nucleic acids related to allergens, contributing significantly to the field of pharmaceutical science and allergy diagnosis.

Latest Patents

Among his latest inventions are patents describing isolated nucleic acids encoding allergens, specifically Der p III. These patents detail a complementary DNA (cDNA) that encodes a peptide with Der p III activity, which has a predicted molecular weight of approximately 24,985 daltons. The applications of these nucleic acids are significant; they can act as probes for detecting Der p III nucleic acids in various samples or facilitate the recombinant production of peptides that exhibit Der p III activity. Such peptides hold potential for use in pharmaceutical compositions and methods for diagnosing sensitivity to house dust mites.

Career Highlights

Throughout his career, Wayne has made substantial contributions while working for prominent companies such as Immulogic Pharmaceutical Corporation and Merck Patent GmbH. These experiences have allowed him to advance his research and innovation in the area of allergen-related technologies.

Collaborations

Wayne has also collaborated with notable colleagues including Kaw-Yan Chua and Geoffrey Alexander Stewart. Their teamwork and combined expertise have fostered advancements in the research and development of allergen diagnostics and treatments.

Conclusion

Wayne Robert Thomas exemplifies dedication to scientific innovation, particularly in the realm of allergy research. His extensive patent portfolio not only illustrates his inventive capabilities but also his commitment to improving health outcomes through advanced diagnostic methods and therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…